Trademark: 87924207
Word
DICERNA PHARMACEUTICALS
Status
Dead
Status Code
606
Status Date
Monday, January 31, 2022
Serial Number
87924207
Mark Type
3000
Filing Date
Wednesday, May 16, 2018
Published for Opposition
Tuesday, October 30, 2018
Abandoned Date
Monday, January 31, 2022

Trademark Owner History
Dicerna Pharmaceuticals, Inc. - Owner At Publication

Classifications
5 Pharmaceutical preparations for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; Oligonucleotide compounds for use in the targeted delivery of RNAi therapy; Pharmaceutical preparations for use in targeted pharmaceutical therapies for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; Chemical compounds in the form of a molecular nanoparticle complex that act as a platform for the delivery of RNA-based drugs to biological cells; drug delivery agents consisting of oligonucleotide compounds that facilitate the delivery of a wide range of pharmaceutical based therapies
42 Research and development of oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; research and development of pharmaceutical preparations for the treatment of liver-based disorders; research and development of oligonucleotide compounds for targeted gene silencing; scientific research and development; scientific investigations for medical purposes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
The mark consists of a vertical double helix positioned to the left of the words "DICERNA PHARMACEUTICALS". The word "DICERNA" is stacked directly above the word "PHARMACEUTICALS". A left pointing arrow head is positioned at the base of the letter "D" of "DICERNA", splicing the double helix.
Color is not claimed as a feature of the mark.
"PHARMACEUTICALS"

Trademark Events
May 25, 2022
Teas Change Of Correspondence Received
May 25, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
May 25, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 2, 2022
Teas Change Of Correspondence Received
Feb 2, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 2, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 31, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Jan 31, 2022
Abandonment - No Use Statement Filed
Jan 13, 2022
Teas Change Of Correspondence Received
Jan 13, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 13, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 5, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Jan 5, 2022
Teas Change Of Correspondence Received
Jan 5, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 5, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 5, 2022
Teas Change Of Owner Address Received
Jun 17, 2021
Notice Of Approval Of Extension Request E-Mailed
Jun 16, 2021
Sou Extension 5 Granted
Jun 10, 2021
Sou Extension 5 Filed
Jun 16, 2021
Case Assigned To Intent To Use Paralegal
Jun 10, 2021
Teas Extension Received
Feb 25, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Feb 25, 2021
Teas Change Of Correspondence Received
Feb 25, 2021
Teas Change Of Owner Address Received
Dec 15, 2020
Notice Of Approval Of Extension Request E-Mailed
Dec 11, 2020
Sou Extension 4 Granted
Dec 11, 2020
Sou Extension 4 Filed
Dec 11, 2020
Teas Extension Received
Jun 19, 2020
Notice Of Approval Of Extension Request E-Mailed
Jun 17, 2020
Sou Extension 3 Granted
Jun 17, 2020
Sou Extension 3 Filed
Jun 17, 2020
Teas Extension Received
Dec 13, 2019
Notice Of Approval Of Extension Request E-Mailed
Dec 11, 2019
Sou Extension 2 Granted
Dec 11, 2019
Sou Extension 2 Filed
Dec 11, 2019
Teas Extension Received
Jun 21, 2019
Notice Of Approval Of Extension Request E-Mailed
Jun 19, 2019
Sou Extension 1 Granted
Jun 19, 2019
Sou Extension 1 Filed
Jun 19, 2019
Teas Extension Received
Jun 10, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 10, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 25, 2018
Noa E-Mailed - Sou Required From Applicant
Oct 30, 2018
Official Gazette Publication Confirmation E-Mailed
Oct 30, 2018
Published For Opposition
Oct 10, 2018
Notification Of Notice Of Publication E-Mailed
Sep 23, 2018
Assigned To Lie
Sep 8, 2018
Approved For Pub - Principal Register
Sep 8, 2018
Examiner's Amendment Entered
Sep 8, 2018
Notification Of Examiners Amendment E-Mailed
Sep 8, 2018
Examiners Amendment E-Mailed
Sep 8, 2018
Examiners Amendment -Written
Sep 7, 2018
Assigned To Examiner
May 25, 2018
Notice Of Design Search Code E-Mailed
May 24, 2018
New Application Office Supplied Data Entered In Tram
May 19, 2018
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24